Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127165531 | 12716553 | 1 | I | 20160826 | 20160830 | 20160906 | 20160906 | EXP | US-PFIZER INC-2016411436 | PFIZER | 72.00 | YR | M | Y | 79.38000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127165531 | 12716553 | 1 | PS | SILDENAFIL CITRATE. | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | TID | ||||||
| 127165531 | 12716553 | 2 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 400 MG, UNK | 0 | 400 | MG | |||||||||
| 127165531 | 12716553 | 3 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 127165531 | 12716553 | 4 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | [BUDESONIDE 160/ FORMOTEROL FUMARATE 4.5] INHALER | 0 | |||||||||||
| 127165531 | 12716553 | 5 | C | CARVEDILOL. | CARVEDILOL | 1 | 6.25 MG, 2X/DAY | 0 | 6.25 | MG | BID | ||||||||
| 127165531 | 12716553 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 127165531 | 12716553 | 7 | C | BUMETANIDE. | BUMETANIDE | 1 | 0.5 MG, UNK | 0 | .5 | MG | |||||||||
| 127165531 | 12716553 | 8 | C | POTASSIUM | POTASSIUM | 1 | 10 MEQ, UNK | 0 | 10 | MEQ | |||||||||
| 127165531 | 12716553 | 9 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | 4 MG, UNK | 0 | 4 | MG | |||||||||
| 127165531 | 12716553 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 127165531 | 12716553 | 11 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 127165531 | 12716553 | 12 | C | COUMADIN | WARFARIN SODIUM | 1 | VARYING DOSE BASED ON INR | 0 | |||||||||||
| 127165531 | 12716553 | 13 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 127165531 | 12716553 | 14 | C | AMIODARONE | AMIODARONE | 1 | 200 MG, UNK | 0 | 200 | MG | |||||||||
| 127165531 | 12716553 | 15 | C | VITAMIN C | ASCORBIC ACID | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 127165531 | 12716553 | 16 | C | IRON | IRON | 1 | 325 MG, UNK | 0 | 325 | MG | |||||||||
| 127165531 | 12716553 | 17 | C | PROBIOTIC | PROBIOTICS NOS | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127165531 | 12716553 | 1 | Cardiac disorder |
| 127165531 | 12716553 | 5 | Blood pressure abnormal |
| 127165531 | 12716553 | 6 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127165531 | 12716553 | HO |
| 127165531 | 12716553 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127165531 | 12716553 | Product use issue | |
| 127165531 | 12716553 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127165531 | 12716553 | 1 | 201606 | 0 |